US Patent Issued to Think Therapeutics on July 22 for "Immunogenic compositions comprising nucleic acids for RAS peptides and their use for treating cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,741, issued on July 22, was assigned to Think Therapeutics Inc. (Newton, Mass.).

"Immunogenic compositions comprising nucleic acids for RAS peptides and their use for treating cancer" was invented by David Kenneth Gifford (Newton, Mass.) and Brandon Carter (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides for methods, systems, and compositions of nucleic acid and peptide sequences. The present disclosure provides for a nucleic acid sequence encoding two or more amino acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, S...